- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Vaso Corporation Announces Financial Results for First Quarter of 2025 | 114 | GlobeNewswire (Europe) | PLAINVIEW, N.Y., May 15, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and healthcare IT services, professional... ► Artikel lesen | |
| 31.03. | VASO Corp - 10-K, Annual Report | 1 | SEC Filings | ||
| 31.03. | Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year 2024 | 145 | GlobeNewswire (Europe) | PLAINVIEW, N.Y., March 31, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and healthcare IT services,... ► Artikel lesen | |
| 13.01. | Vaso Corporation Announces Executive Leadership Appointments & Names New Vice Chairman to the Board of Directors | 129 | GlobeNewswire (Europe) | PLAINVIEW, N.Y, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO), a leader in human capital, information technology and MedTech, today announced new executive appointments... ► Artikel lesen | |
| 03.01. | VASO Corp - 8-K, Current Report | - | SEC Filings | ||
| 20.12.24 | SRV YHTIOT OYJ: SRV will implement right-of-occupancy housing units for Vaso in Kuloistenniitty, Raisio - the units will have an energy class A rating | 4 | Cision News | ||
| VASO Aktie jetzt für 0€ handeln | |||||
| 16.12.24 | Vaso Corporation CEO Reflects on a Year of Growth and Innovation in End-of-Year Letter Setting the Tone for a Promising 2025 | 128 | GlobeNewswire (Europe) | Vaso Corporation137 Commercial StreetPlainview, New York 11803Tel: (516) 997-4600 Fax: (516) 997-2299 NEWS RELEASE PLAINVIEW, N.Y., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX:... ► Artikel lesen | |
| 14.11.24 | Vaso Corporation Announces Financial Results for Third Quarter 2024 | 146 | GlobeNewswire (Europe) | PLAINVIEW, N.Y., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO), a leading medtech company with a diversified business portfolio in network and healthcare IT services, professional... ► Artikel lesen | |
| 19.09.24 | Vaso Corporation Announces Termination of Business Combination Agreement with Achari Ventures Holdings Corp. I | 156 | GlobeNewswire (Europe) | PLAINVIEW, N.Y., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO) today announced that it has provided notice to Achari Ventures Holdings Corp. I ("Achari") to terminate... ► Artikel lesen | |
| 14.08.24 | Vaso Corporation Announces Financial Results for Second Quarter 2024 | 134 | GlobeNewswire (Europe) | High deferred revenue and backlog setting stage for 2024 revenue and income growth PLAINVIEW, N.Y., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO) today reported its operating... ► Artikel lesen |
10 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 22,865 | +3,13 % | Bayer-Aktie: Kurs klettert leicht (23,995 €) | An der deutschen Börse liegt das Wertpapier von Bayer aktuell im Plus. Die Aktie notiert gegenwärtig bei 24,00 Euro. Am Aktienmarkt liegt die Aktie von Bayer zur Stunde im Plus. Das Wertpapier legte... ► Artikel lesen | |
| ASTRAZENECA | 120,85 | +1,47 % | AKTIEN IM FOKUS: Kursrutsch bei Pharmawerten - Trump setzt Branche unter Druck | ZÜRICH/LONDON/PARIS (dpa-AFX) - Aktien aus dem Pharmasektor sind am Montag schwer unter Druck geraten wegen Sorgen um die Profitabilität im US-Geschäft. US-Präsident Donald Trump will die Preise für... ► Artikel lesen | |
| EYEPOINT PHARMACEUTICALS | 4,997 | -2,21 % | EyePoint Pharmaceuticals, Inc.: EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | WATERTOWN, Mass., April 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of... ► Artikel lesen | |
| IONIS PHARMACEUTICALS | 28,870 | -0,03 % | Ionis Pharmaceuticals, Inc.: Ionis expands partnership with Sobi to include olezarsen commercialization outside the U.S. | - Agreement enables olezarsen to reach people living with conditions associated with elevated triglycerides across the world - - Ionis will continue to independently commercialize TRYNGOLZA (olezarsen)... ► Artikel lesen | |
| CSPC PHARMA | 0,639 | -3,50 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - EXCLUSIVE LICENSE AGREEMENT WITH CIPLA USA, INC. FOR IRINOTECAN LIPOSOME INJECTION | ||
| ACADIA PHARMACEUTICALS | 15,555 | -1,18 % | Acadia Pharmaceuticals files to sell 43.58M shares of common stock for holders | ||
| SELLAS LIFE SCIENCES | 1,436 | 0,00 % | SELLAS Life Sciences Group, Inc.: SELLAS Life Sciences Announces First Pediatric AML Patient Dosed in the Ongoing Phase 2 Trial of SLS009 r/r AML | NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ("SELLAS'' or the "Company"), a late-stage clinical biopharmaceutical company focused on the development of... ► Artikel lesen | |
| MADRIGAL PHARMACEUTICALS | 253,40 | -2,80 % | Madrigal's liver disease drug Rezdiffra shows promise in compensated MASH cirrhosis | ||
| CATALYST PHARMACEUTICALS | 21,280 | +0,05 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Announces Health Canada's Acceptance of AGAMREE New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals | CORAL GABLES, Fla., April 08, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing... ► Artikel lesen | |
| ENZON PHARMACEUTICALS | 0,071 | 0,00 % | ENZON PHARMACEUTICALS, INC. - 10-Q, Quarterly Report | ||
| CHUGAI PHARMACEUTICAL | 45,490 | 0,00 % | Dividendenbekanntmachungen (27.12.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADWAYS INC JP3121970002 3 JPY 0,0182 EUR AGC INC JP3112000009 105 JPY 0,6373 EUR ALERUS FINANCIAL CORPORATION US01446U1034 0... ► Artikel lesen | |
| OPUS GENETICS | 0,866 | +2,36 % | Opus Genetics, Inc. - 10-Q, Quarterly Report | ||
| ELITE PHARMACEUTICALS | - | - | Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals Announces Commercial Launch of Oxycodone and Acetaminophen Tablets | Northvale, New Jersey--(Newsfile Corp. - April 30, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products... ► Artikel lesen | |
| VIRACTA THERAPEUTICS | 0,010 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 10.02.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 10.02.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 10.02.2025ISIN NameES0105015012 LAR... ► Artikel lesen | |
| SAVARA | 2,680 | -3,60 % | Savara GAAP EPS of -$0.12 beats by $0.01 |
Das Unternehmen VASO CORPORATION kann der Branche Pharma zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VASO CORPORATION finden Sie auf Wallstreet Online.